SPOTLIGHT -
Perinatal Women’s Views of Pharmacist-Delivered Perinatal Depression Screening
Pharmacists are ideally positioned within communities to identify patients struggling with perinatal depression.
Read More
Larotrectinib Treats NTRK Gene Fusion-Positive Cancers Successfully With Low Rates of Adverse Effects
Larotrectinib was the first drug to receive accelerated FDA approval for patients of all ages based on a common molecular marker, independent of tissue origin for targeted therapy.
Olaparib: The First PARP Inhibitor With 7 Indications Across 4 Tumor Types
Olaparib was the first PARP inhibitor to be developed and has been the most studied.
Oncology Overview: Regorafenib For Metastatic Colorectal Cancer, Gastrointestinal Stromal Tumor, Hepatocellular Carcinoma
The FDA initially approved regorafenib for chemorefractory metastatic colorectal cancer and unresectable gastrointestinal stromal tumor in 2012.
Moms Are Not OK: Understand, Recognize, and Treat Postpartum Depression
Common and debilitating, the mental health condition is often underdiagnosed and undertreated.
Druggable Targets for Melanoma: Skin Aquaporins
AQP-modulating agent discovery has proved challenging, but many powerful AQP3 permeating molecules have been identified.
Pharmacist-Led Sun Safety Education Can Expand Skin Cancer Awareness
A recent study proved community pharmacies are model settings for skin cancer prevention education in rural communities with insufficient access to health care services.
Using Store-and-Forward Teledermatology to Evaluate Potential Skin Cancers
Pharmacists’ vast health care knowledge and community accessibility makes them ideal patient liaisons.
